{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:07:30Z","timestamp":1763017650918},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/tp.0000000000001197","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T13:31:19Z","timestamp":1462282279000},"page":"2342-2351","source":"Crossref","is-referenced-by-count":11,"title":["Modulation of Donor-Specific Antibody Production After Organ Transplantation by Valproic Acid"],"prefix":"10.1097","volume":"100","author":[{"given":"Junsheng","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210211","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOT.0000000000000235","article-title":"Antibody-mediated rejection","volume":"20","author":"Westall","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R2-20-20210211","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2014.08.014","article-title":"Lights and shadows of anti-HLA antibodies detected by solid-phase assay","volume":"162","author":"Picascia","year":"2014","journal-title":"Immunol Lett"},{"key":"R3-20-20210211","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-6143.2006.01644.x","article-title":"Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival","volume":"7","author":"Terasaki","year":"2007","journal-title":"Am J Transplant"},{"key":"R4-20-20210211","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/ki.2010.436","article-title":"Emerging role of B cells in chronic allograft dysfunction","volume":"119","author":"Colvin","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"R5-20-20210211","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nri3216","article-title":"Immunoglobulin class-switch DNA recombination: induction, targeting and beyond","volume":"12","author":"Xu","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R6-20-20210211","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"R7-20-20210211","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/08916934.2012.749244","article-title":"Regulation of Aicda expression and AID activity","volume":"46","author":"Zan","year":"2013","journal-title":"Autoimmunity"},{"key":"R8-20-20210211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.immunol.26.021607.090241","article-title":"Regulation and functions of Blimp-1 in T and B lymphocytes","volume":"26","author":"Martins","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"R9-20-20210211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.immuni.2004.06.010","article-title":"XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation","volume":"21","author":"Shaffer","year":"2004","journal-title":"Immunity"},{"key":"R10-20-20210211","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.it.2008.07.006","article-title":"Interferon regulatory factor 4 and 8 in B-cell development","volume":"29","author":"Lu","year":"2008","journal-title":"Trends Immunol"},{"key":"R11-20-20210211","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/epi.25201","article-title":"Epigenetic modulation of the immune function: a potential target for tolerance","volume":"8","author":"Su\u00e1rez-\u00c1lvarez","year":"2013","journal-title":"Epigenetics"},{"key":"R12-20-20210211","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12094-010-0527-3","article-title":"Epigenetic therapy of lymphoma using histone deacetylase inhibitors","volume":"12","author":"Cotto","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"R13-20-20210211","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1078-0432.CCR-14-1290","article-title":"Selective inhibition of HDAC1 and HDAC2 as a potential therapeutic option for B-ALL","volume":"21","author":"Stubbs","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R14-20-20210211","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/onc.2013.482","article-title":"The role of p21(waf1\/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the E\u03bc-myc model of B-cell lymphoma","volume":"33","author":"Newbold","year":"2014","journal-title":"Oncogene"},{"key":"R15-20-20210211","doi-asserted-by":"crossref","first-page":"i46","DOI":"10.1136\/annrheumdis-2011-200593","article-title":"HDAC inhibitor therapy in autoimmunity and transplantation","volume":"71","author":"Hancock","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R16-20-20210211","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J"},{"key":"R17-20-20210211","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"R18-20-20210211","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.4049\/jimmunol.1401702","article-title":"Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses","volume":"193","author":"White","year":"2014","journal-title":"J Immunol"},{"key":"R19-20-20210211","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1080\/10428190701344907","article-title":"Valproic acid monotherapy leads to CR in a patient with refractory diffuse large B cell lymphoma","volume":"48","author":"Zain","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"R20-20-20210211","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.jaci.2013.01.018","article-title":"Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid","volume":"131","author":"Kienzler","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"R21-20-20210211","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00007890-199611150-00016","article-title":"Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations","volume":"62","author":"Zhang","year":"1996","journal-title":"Transplantation"},{"key":"R22-20-20210211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjc.6603851","article-title":"Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial","volume":"97","author":"Atmaca","year":"2007","journal-title":"Br J Cancer"},{"key":"R23-20-20210211","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2006.08.6165","article-title":"Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study","volume":"25","author":"M\u00fcnster","year":"2007","journal-title":"J Clin Oncol"},{"key":"R24-20-20210211","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.4049\/jimmunol.1401849","article-title":"IgH chain class switch recombination: mechanism and regulation","volume":"193","author":"Stavnezer","year":"2014","journal-title":"J Immunol"},{"key":"R25-20-20210211","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.tiv.2014.04.001","article-title":"Developmental cardiotoxicity effects of four commonly used antiepileptic drugs in embryonic chick heart micromass culture and embryonic stem cell culture systems","volume":"28","author":"Ahir","year":"2014","journal-title":"Toxicol In Vitro"},{"key":"R26-20-20210211","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.yexcr.2011.11.012","article-title":"Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD\/SCID mice","volume":"318","author":"Vulcano","year":"2012","journal-title":"Exp Cell Res"},{"key":"R27-20-20210211","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1111\/petr.12347","article-title":"HLA desensitization with bortezomib in a highly sensitized pediatric patient","volume":"18","author":"May","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R28-20-20210211","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/TP.0b013e31823f7eea","article-title":"Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients","volume":"93","author":"Morrow","year":"2012","journal-title":"Transplantation"},{"key":"R29-20-20210211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trim.2013.09.010","article-title":"Sustained reduction of alloantibody secreting plasma cells and donor specific antibody with proteasome inhibition in mice","volume":"29","author":"Redfield","year":"2013","journal-title":"Transpl Immunol"},{"key":"R30-20-20210211","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/00007890-199806150-00014","article-title":"Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice","volume":"65","author":"Br\u00e4ndle","year":"1998","journal-title":"Transplantation"},{"key":"R31-20-20210211","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.1002983","article-title":"B lymphocytes differentially influence acute and chronic allograft rejection in mice","volume":"186","author":"DiLillo","year":"2011","journal-title":"J Immunol"},{"key":"R32-20-20210211","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.it.2013.03.006","article-title":"Epigenetics of the antibody response","volume":"34","author":"Li","year":"2013","journal-title":"Trends Immunol"},{"key":"R33-20-20210211","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1084\/jem.20081678","article-title":"S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination","volume":"206","author":"Wang","year":"2009","journal-title":"J Exp Med"},{"key":"R34-20-20210211","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/tri.12265","article-title":"Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors","volume":"27","author":"Sugimoto","year":"2014","journal-title":"Transpl Int"},{"key":"R35-20-20210211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/TP.0b013e318295c04d","article-title":"Effects of trichostatin A in a rat model of acute graft-versus-host disease after liver transplantation","volume":"96","author":"Xia","year":"2013","journal-title":"Transplantation"},{"key":"R36-20-20210211","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1128\/MCB.01206-10","article-title":"Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival","volume":"31","author":"Beier","year":"2011","journal-title":"Mol Cell Biol"},{"key":"R37-20-20210211","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.0400380101","article-title":"Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect","volume":"101","author":"Reddy","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-20-20210211","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trim.2009.04.006","article-title":"Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model","volume":"21","author":"Kinugasa","year":"2009","journal-title":"Transpl Immunol"},{"key":"R39-20-20210211","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"R40-20-20210211","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.1008522107","article-title":"Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair","volume":"107","author":"Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R41-20-20210211","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1084\/jem.20132613","article-title":"Germinal center B cell maintenance and differentiation are controlled by distinct NF-\u03baB transcription factor subunits","volume":"211","author":"Heise","year":"2014","journal-title":"J Exp Med"},{"key":"R42-20-20210211","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt.1759","article-title":"Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes","volume":"29","author":"Bantscheff","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R43-20-20210211","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/ni1357","article-title":"Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination","volume":"7","author":"Klein","year":"2006","journal-title":"Nat Immunol"},{"key":"R44-20-20210211","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2006.07.009","article-title":"Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation","volume":"25","author":"Sciammas","year":"2006","journal-title":"Immunity"},{"key":"R45-20-20210211","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2011-10-292003","article-title":"Histone\/protein deacetylases and T-cell immune responses","volume":"119","author":"Akimova","year":"2012","journal-title":"Blood"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:23:32Z","timestamp":1620977012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201611000-00020"}},"subtitle":["A Histone Deacetylase Inhibitor"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001197","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}